Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Preeya K Gupta

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Therapeutic Advances in Ophthalmology|May 21, 2021
The role of KPI-121 0.25% in the treatment of dry eye disease: penetrating the mucus barrier to treat periodic flaresPreeya K Gupta, Nandini Venkateswaran
Ophthalmology and Therapy|November 13, 2016
Need for Animal Models of Meibomian Gland DysfunctionLouis Tong, Preeya K Gupta
Cornea|October 9, 2024
Comprehensive Assessment of the Meibomian Glands by Meibography: Why the Upper Eyelids MatterPreeya K Gupta, Paul Karpecki
Clinical Ophthalmology (Auckland, N.Z.)|February 5, 2021
Meibomian Gland Morphology Among Patients Presenting for Refractive Surgery EvaluationCassandra C Brooks, Preeya K Gupta
Current Opinion in Ophthalmology|June 10, 2015
Intense pulsed light therapy for the treatment of evaporative dry eye diseaseGargi K Vora, Preeya K Gupta
Ophthalmology and Therapy|August 21, 2015
The Future of Dry Eye Treatment: A Glance into the Therapeutic PipelineLaura A Vickers, Preeya K Gupta
Current Opinion in Ophthalmology|April 2, 2016
Femtosecond laser-assisted keratotomyLaura A Vickers, Preeya K Gupta
Clinical Ophthalmology (Auckland, N.Z.)|June 6, 2017
Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapyMorgan R Godin, Preeya K Gupta
International Ophthalmology Clinics|June 4, 2016
Current Theories and Methods for Managing Negative DysphotopsiaGarett S Frank, Preeya K Gupta
Clinical Ophthalmology (Auckland, N.Z.)|February 17, 2022
Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye DiseaseNandini Venkateswaran, Yandong Bian, Preeya K Gupta
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Therapeutic Advances in Ophthalmology|May 21, 2021
The role of KPI-121 0.25% in the treatment of dry eye disease: penetrating the mucus barrier to treat periodic flaresPreeya K Gupta, Nandini Venkateswaran
Ophthalmology and Therapy|November 13, 2016
Need for Animal Models of Meibomian Gland DysfunctionLouis Tong, Preeya K Gupta
Cornea|October 9, 2024
Comprehensive Assessment of the Meibomian Glands by Meibography: Why the Upper Eyelids MatterPreeya K Gupta, Paul Karpecki
Clinical Ophthalmology (Auckland, N.Z.)|February 5, 2021
Meibomian Gland Morphology Among Patients Presenting for Refractive Surgery EvaluationCassandra C Brooks, Preeya K Gupta
Current Opinion in Ophthalmology|June 10, 2015
Intense pulsed light therapy for the treatment of evaporative dry eye diseaseGargi K Vora, Preeya K Gupta
Ophthalmology and Therapy|August 21, 2015
The Future of Dry Eye Treatment: A Glance into the Therapeutic PipelineLaura A Vickers, Preeya K Gupta
Current Opinion in Ophthalmology|April 2, 2016
Femtosecond laser-assisted keratotomyLaura A Vickers, Preeya K Gupta
Clinical Ophthalmology (Auckland, N.Z.)|June 6, 2017
Lifitegrast ophthalmic solution in the treatment of signs and symptoms of dry eye disease: design, development, and place in therapyMorgan R Godin, Preeya K Gupta
International Ophthalmology Clinics|June 4, 2016
Current Theories and Methods for Managing Negative DysphotopsiaGarett S Frank, Preeya K Gupta
Clinical Ophthalmology (Auckland, N.Z.)|February 17, 2022
Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye DiseaseNandini Venkateswaran, Yandong Bian, Preeya K Gupta
Pageof 8